Google AI
The Times Australia
The Times World News

.

I have mild COVID – should I take the antiviral Paxlovid?

  • Written by Mark Morgan, Professor of general practice, Bond University
I have mild COVID – should I take the antiviral Paxlovid?Shutterstock

The COVID medication Paxlovid has been available in Australia on the Pharmaceuticals Benefits Scheme (PBS) since the start of May, with eligible patients directed to talk to their GP for a prescription.

Paxlovid is an oral treatment for mild COVID, taken as a tablet, which has two active ingredients: nirmatrelvir and ritonavir....

Read more: I have mild COVID – should I take the antiviral Paxlovid?

Times Magazine

Why Is Professional Porsche Servicing Important for Performance and Longevity?

Owning a Porsche is a symbol of precision engineering, luxury, and high performance. To maintain t...

6 ways your smartwatch is lying to you, according to science

You check your smartwatch after a run. Your fitness score has dropped. You’ve burnt hardly any...

Has the adoption of electric vehicles led to new forms of electricity theft

Why the concern exists Electric vehicles (EVs) like the Tesla Model 3 or Nissan Leaf shift “fue...

Adobe Ushers in a New Era of Creativity with New Creative Agent and Generative AI Innovations in Adobe Firefly

Adobe (Nasdaq: ADBE) — the global technology leader that unleashes creativity, productivity and ...

CRO Tech Stack: A Technical Guide to Conversion Rate Optimization Tools

The fascinating thing is that the value of this website lies in the fact that creating a high-cali...

How Decentralised Applications Are Reshaping Enterprise Software in Australia

Australian businesses are experiencing a quiet revolution in how they manage data, execute agreeme...

Technology

6 ways your smartwatch is lying to you, accor…

You check your smartwatch after a run. Your fitness score has dropped. You’ve burnt hardly any...

Local News

Court outcome reinforces wildlife traffick…

A 20-year-old man has been fined close to $50,000 and ordered to pay costs after pleading guilty t...

Culture

Olivia Colman, Kate Box to join an exclusive …

Fresh out of cinemas, JIMPA - the new film by acclaimed director Sophie Hyde (Good Luck to you, ...

Travel

Holidays: How to Book a Flight — and Protect …

For decades, booking an overseas holiday was a straightforward transaction: choose your destinat...

The Times Features

realestate.com.au attracts the buyer for 9 in 10 listed…

New PropTrack data reveals the impact realestate.com.au has on property sales, with the  platfor...

The Hidden Threat Inside Data Centers: Why Fuel Degrada…

Data centers are designed with one overriding objective: uninterrupted operation. To achieve this...

Holidays: How to Book a Flight — and Protect Your Money…

For decades, booking an overseas holiday was a straightforward transaction: choose your destinat...

Olivia Colman, Kate Box to join an exclusive Live Q…

Fresh out of cinemas, JIMPA - the new film by acclaimed director Sophie Hyde (Good Luck to you, ...

Homemade Food: Cheaper Than Takeaway, Healthier Than Yo…

As the cost of living continues to bite across Australia, households are taking a harder look at...

The Coalition wants NDIS reform to focus on 3 things. H…

The government is expected to announce further changes to the National Disability Insurance Sche...

Power Bills: What Are the Options to Decrease What a Fa…

Australian households are being told, repeatedly, to “use less power.” Turn off lights. Shorten...

The Times Launches Dedicated Property Advertising Platf…

In a significant expansion of its digital media offering, The Times has formally launched TimesA...

Can I get a free flu shot? And will it cover ‘super K’?…

For many of us, flu can mean a nasty few weeks of illness. But for the very young and old, and...